Sandstone Diagnostics Raises Additional Series A Financing to Accelerate Zero Delay™ Plasma Technology Development View more
New Study Utilizing Miromesh® Biologic Matrix Reports Excellent Patient Outcomes with No Reinterventions View more
SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease View more
